13F-HR filed by DEERFIELD MANAGEMENT COMPANY, L.P.
DEERFIELD MANAGEMENT COMPANY, L.P. filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-16, with 122 holding rows worth $4,472,946,000.
- Accession
- 0000950159-22-000122
- Filer
- CIK 1009258
- Filed
- 2022-05-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2022
A holdings report, 122 entries on the cover page, a total value of $4,472,946,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,472,946,000 with VALUE read as thousands by filing date, 13F file number 028-05366. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFlynn Management LLC028-11827
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GLAUKOS CORP | 377322AB8 | BOND | 269,897,000 | $358,786,000 | thousands by filing date | principal |
| NUVALENT INC COM | 670703107 | Stock | 19,341,024 | $268,647,000 | thousands by filing date | |
| VIATRIS INC COM | 92556V106 | Stock | 20,673,700 | $224,930,000 | thousands by filing date | |
| ADAPTHEALTH CORP | 00653Q102 | COMMON STOCK | 11,650,072 | $186,751,000 | thousands by filing date | |
| INVITAE CORP | 46185LAB9 | NOTE 2.000% 9/0 | 206,873,000 | $169,769,000 | thousands by filing date | principal |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 1,657,800 | $155,419,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771VAB4 | NOTE 1.500%10/0 | 157,390,000 | $141,877,000 | thousands by filing date | principal |
| ENVISTA HOLDINGS CORPORATION | 29415FAB0 | BOND | 52,500,000 | $123,924,000 | thousands by filing date | principal |
| CAREMAX INC | 14171W103 | COM | 15,861,090 | $121,813,000 | thousands by filing date | |
| NATERA INC | 632307AB0 | BOND | 90,638,000 | $120,177,000 | thousands by filing date | principal |
| SAREPTA THERAPEUTICS INC | 803607AB6 | DBCV 1.500%11/1 | 88,657,000 | $116,124,000 | thousands by filing date | |
| PACIRA BIOSCIENCES INC | 695127AF7 | NOTE 0.750% 8/0 | 81,600,000 | $100,908,000 | thousands by filing date | principal |
| NUVASIVE INC | 670704AL9 | BOND | 96,966,000 | $96,433,000 | thousands by filing date | principal |
| PULMONX CORP | 745848101 | COM | 3,695,341 | $91,681,000 | thousands by filing date | |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 2,153,712 | $88,927,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 4,891,996 | $82,332,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753UAB2 | NOTE 3.500% 9/1 | 51,885,000 | $81,724,000 | thousands by filing date | principal |
| TABULA RASA HEALTHCARE INC | 873379AA9 | NOTE | 107,816,000 | $79,740,000 | thousands by filing date | principal |
| INSULET CORP | 45784PAK7 | NOTE 0.375% 9/0 | 57,581,000 | $76,232,000 | thousands by filing date | principal |
| NUVASIVE INC | 670704AJ4 | NOTE 0.375% 3/1 | 80,000,000 | $76,133,000 | thousands by filing date | principal |
| INSMED INC | 457669AA7 | NOTE 1.750% 1/1 | 75,000,000 | $74,929,000 | thousands by filing date | principal |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 3,282,912 | $72,290,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 4,416,361 | $71,015,000 | thousands by filing date | |
| NEVRO CORP | 64157FAC7 | NOTE 2.750% 4/0 | 61,000,000 | $65,368,000 | thousands by filing date | principal |
| ORGANOGENESIS HOLDINGS INC | 68621F102 | COMMON STOCK | 8,456,876 | $64,441,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845PAA6 | NOTE 3.250% 7/0 | 57,791,000 | $52,992,000 | thousands by filing date | principal |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 5,580,456 | $51,731,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 465,000 | $48,923,000 | thousands by filing date | |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 80,000,000 | $47,402,000 | thousands by filing date | principal |
| CENTENE CORP DEL COM | 15135B101 | Stock | 553,800 | $46,624,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 765,489 | $45,508,000 | thousands by filing date | |
| MOLINA HEALTHCARE INC | 60855R100 | COM | 134,989 | $45,031,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 4,695,020 | $42,725,000 | thousands by filing date | |
| SEMA4 HOLDINGS CORP | 81663L101 | COM | 13,848,488 | $42,515,000 | thousands by filing date | |
| SINGULAR GENOMICS SYSTEMS IN | 82933R100 | COM | 6,612,019 | $41,722,000 | thousands by filing date | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 3,594,829 | $41,341,000 | thousands by filing date | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 3,933,137 | $38,151,000 | thousands by filing date | |
| BROOKDALE SR LIVING INC | 112463104 | COM | 5,379,000 | $37,922,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 952,703 | $35,069,000 | thousands by filing date | |
| 1LIFE HEALTHCARE INC | 68269GAB3 | BOND | 40,000,000 | $34,716,000 | thousands by filing date | principal |
| STARLING ONCOLOGY INC | 68236X100 | COMMON STOCK | 3,296,107 | $32,137,000 | thousands by filing date | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 1,577,078 | $28,600,000 | thousands by filing date | |
| NOVAVAX INC | 670002AB0 | NOTE 3.750% 2/0 | 25,000,000 | $26,777,000 | thousands by filing date | principal |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 3,672,808 | $25,269,000 | thousands by filing date | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 5,830,249 | $23,613,000 | thousands by filing date | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 891,587 | $22,744,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 270,000 | $22,199,000 | thousands by filing date | |
| GLAUKOS CORP COM | 377322102 | Stock | 369,514 | $21,365,000 | thousands by filing date | |
| XERIS PHARMACEUTICALS INC | 98422LAA5 | NOTE 5.000% 7/1 | 18,000,000 | $21,095,000 | thousands by filing date | principal |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 2,086,449 | $20,698,000 | thousands by filing date | |
| GOODRX HLDGS INC | 38246G108 | COM CL A | 979,106 | $18,926,000 | thousands by filing date | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 3,577,233 | $18,816,000 | thousands by filing date | |
| OUTSET MEDICAL INC | 690145107 | COM | 400,622 | $18,188,000 | thousands by filing date | |
| HEALTH CATALYST INC | 42225TAB3 | BOND | 15,000,000 | $17,171,000 | thousands by filing date | principal |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 3,470,675 | $16,520,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 1,012,000 | $16,455,000 | thousands by filing date | |
| DA32 LIFE SCNCE TEC ACQSTN C | 23312M106 | CLASS A COM | 1,600,000 | $15,544,000 | thousands by filing date | |
| PROFOUND MED CORP | 74319B502 | COM NEW | 1,713,797 | $15,424,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366JAB7 | NOTE | 14,527,000 | $15,076,000 | thousands by filing date | principal |
| ALECTOR INC | 014442107 | COMMON STOCK | 1,055,192 | $15,036,000 | thousands by filing date | |
| Xilio Therapeutics Inc. | 98422T100 | COM | 2,078,692 | $14,696,000 | thousands by filing date | |
| OAK STR HEALTH INC | 67181AAB3 | BOND | 18,000,000 | $14,316,000 | thousands by filing date | principal |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 249,988 | $14,109,000 | thousands by filing date | |
| EVOLUS INC | 30052C107 | COM | 1,229,234 | $13,792,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 830,472 | $12,241,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,601,000 | $11,991,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 437,000 | $11,554,000 | thousands by filing date | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 985,568 | $11,097,000 | thousands by filing date | |
| APOLLO ENDOSURGERY INC | 03767D108 | COM | 1,750,000 | $10,588,000 | thousands by filing date | |
| SARISSA CAPITAL ACQUISITN CO | G7823W102 | CMN | 999,999 | $9,900,000 | thousands by filing date | |
| EUCRATES BIOMEDICAL ACQU COR | G3141W106 | CMN | 999,999 | $9,840,000 | thousands by filing date | |
| SENIOR CONNECT ACQUISITN COR | 81723H108 | COM CL A | 1,000,000 | $9,820,000 | thousands by filing date | |
| REVOLUTION HEALTHCAR AQ CORP | 76155Y108 | CMN | 1,000,000 | $9,810,000 | thousands by filing date | |
| TRISALUS LIFE SCIENCES INC COM | 58507N105 | Stock | 999,999 | $9,800,000 | thousands by filing date | |
| INOZYME PHARMA INC | 45790W108 | COM | 2,344,786 | $9,590,000 | thousands by filing date | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 584,136 | $8,803,000 | thousands by filing date | |
| NYXOAH S A | B6S7WD106 | SHS | 455,262 | $8,714,000 | thousands by filing date | |
| TURMERIC ACQUISITION CORP | G9127T108 | CMN | 750,000 | $7,388,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 304,572 | $7,157,000 | thousands by filing date | |
| IGNYTE ACQUISITION CORP | 45175H106 | CMN | 725,000 | $7,134,000 | thousands by filing date | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 2,345,959 | $6,967,000 | thousands by filing date | |
| QUANTUM SI INC | 74765K105 | COM CL A | 1,400,000 | $6,552,000 | thousands by filing date | |
| GRAYBUG VISION INC COM | 38942Q103 | SHS | 5,281,713 | $6,497,000 | thousands by filing date | |
| BENEFITFOCUS INC | 08180DAB2 | BOND | 6,500,000 | $6,311,000 | thousands by filing date | |
| ONCORUS INC | 68236R103 | COM | 3,148,977 | $5,605,000 | thousands by filing date | |
| VINCERX PHARMA INC | 92731L106 | COM NEW | 1,379,310 | $5,517,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 6,949,416 | $4,948,000 | thousands by filing date | |
| ORION ACQUISITION CORP | 68626A108 | CMN | 500,000 | $4,885,000 | thousands by filing date | |
| WEREWOLF THERAPEUTICS INC | 95075A107 | CMN | 958,125 | $4,216,000 | thousands by filing date | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 375,585 | $3,932,000 | thousands by filing date | |
| ACUTUS MED INC | 005111109 | COM | 2,648,386 | $3,681,000 | thousands by filing date | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 238,865 | $3,638,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 291,005 | $3,352,000 | thousands by filing date | |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 500,000 | $3,200,000 | thousands by filing date | |
| GLAUKOS CORP COM | 377322102 | Stock | 45,200 | $2,613,000 | thousands by filing date | call |
| NEOGENOMICS INC | 64049MAB6 | NOTE 0.250% 1/1 | 2,500,000 | $1,666,000 | thousands by filing date | principal |
| AMERICAN WELL CORP | 03044L105 | CL A | 391,115 | $1,647,000 | thousands by filing date | |
| ANNEXON INC | 03589W102 | COM | 583,913 | $1,594,000 | thousands by filing date | |
| BIOATLA INC | 09077B104 | COM | 289,002 | $1,445,000 | thousands by filing date | |
| The Oncology Institute Inc W Exp 99/99/999 | 68236X118 | SPAC Combination | 1,250,000 | $1,438,000 | thousands by filing date | |
| CAREMAX INC | 14171W111 | *W EXP 06/08/202 | 672,000 | $1,277,000 | thousands by filing date | |
| MEDAVAIL HOLDINGS INC | 58406B103 | COM | 1,142,552 | $1,110,000 | thousands by filing date | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 464,252 | $942,000 | thousands by filing date | |
| ROIVANT SCIENCES LTD | G76279119 | *W EXP 09/30/202 | 1,000,000 | $880,000 | thousands by filing date | |
| BUTTERFLY NETWORK INC | 124155110 | *W EXP 02/12/202 | 733,333 | $748,000 | thousands by filing date | |
| QUANTUM SI INC | 74765K113 | *W EXP 06/10/202 | 333,333 | $383,000 | thousands by filing date | |
| SOMALOGIC INC | 83444k113 | WT | 120,000 | $257,000 | thousands by filing date | |
| NUVATION BIO INC | 67080N119 | WARR | 166,666 | $135,000 | thousands by filing date | |
| IGNYTE ACQUISITION CORP | 45175H114 | *W EXP 01/05/202 | 362,500 | $132,000 | thousands by filing date | |
| SARISSA CAPITAL ACQUISITN CO | G7823W110 | *W EXP 10/23/202 | 333,333 | $120,000 | thousands by filing date | |
| SENIOR CONNECT ACQUISITN COR | 81723H116 | *W EXP 12/31/202 | 500,000 | $90,000 | thousands by filing date | |
| REVOLUTION HEALTHCAR AQ CORP | 76155Y116 | *W EXP 12/31/202 | 200,000 | $90,000 | thousands by filing date | |
| MEDTECH ACQUISITION CORP | 58507N113 | *W EXP 12/22/202 | 333,333 | $85,000 | thousands by filing date | |
| TURMERIC ACQUISITION CORP | G9127T124 | WTS | 250,000 | $82,000 | thousands by filing date | |
| EUCRATES BIOMEDICAL ACQU COR | G3141W122 | *W EXP 10/23/202 | 333,333 | $62,000 | thousands by filing date | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 166,666 | $42,000 | thousands by filing date | |
| ORION ACQUISITION CORP | 68626A116 | WTS | 125,000 | $39,000 | thousands by filing date | |
| WINDTREE THERAPEUTICS INC | 97382D303 | COM | 20,148 | $23,000 | thousands by filing date | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 470 | $10,000 | thousands by filing date | |
| MEDTECH ACQUISITION CORP | 58507N204 | UNIT 12/18/2025 | 1 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| EUCRATES BIOMEDICAL ACQU COR | G3141W114 | UNIT 10/23/2027 | 1 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| SARISSA CAPITAL ACQUISITN CO | G7823W128 | UNIT 10/23/2027 | 1 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950159-22-000122 | this filing | 2022-05-16 | acceptance time not in the bulk data set |